Price-file publication check · 45 CFR § 180
F · 55
This hospital's published file contains little of what § 180 requires.
●Machine-readable file published: assessment threshold met
○Gross / standard charges: below assessment threshold
○Discounted cash price: below assessment threshold
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
20,889
Insurances with rates
11
CPT / HCPCS codes
13,112
Most expensive procedures (gross)
25682-028-01
$119,052
RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [190114]
Gross
$183,157
25682-025-0125682-028-01
$100,292
RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [190114]
Gross
$154,296
50242-150-01
$60,154
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION [178568]
Gross
$92,544
0003-7125-11
$48,726
NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION [194379]
Gross
$74,963
75987-080-10
$44,008
PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION [148751]
Gross
$67,705
0469-4425-30
$39,000
ZOLBETUXIMAB-CLZB 300 MG INTRAVENOUS SOLUTION [205659]
Gross
$60,000
0173-0898-03
$38,162
DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION [191781]
Gross
$58,710
0003-2328-22
$32,560
IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION [150564]
Gross
$50,093
51144-050-01
$29,050
BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION [153019]
Gross
$44,692
72493-103-03
$27,242
MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT [188495]
Gross
$41,911
72903-853-01
$26,710
MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION [195098]
Gross
$41,092
47335-177-95
$24,865
TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE [182767]
Gross
$38,254
57894-505-20
$24,676
DARATUMUMAB 20 MG/ML INTRAVENOUS SOLUTION [173332]
Gross
$37,964
59572-775-01
$24,333
LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION [187194]
Gross
$37,435
50881-006-03
$23,957
RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION [197773]
Gross
$36,858
57894-501-01
$23,701
AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION [192080]
Gross
$36,463
0006-3026-04
$20,000
PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [169519]
Gross
$30,770
0310-4611-50
$19,537
DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION [179453]
Gross
$30,057
76100272
$18,947
HC BRONCHOSCOPY W_PLMT FIDUCIAL MARKERS SINGLE_MULT
Gross
$29,150
50242-917-01
$18,555
ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION [175551]
Gross
$28,546
61755-008-01
$17,722
CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION [183555]
Gross
$27,265
57894-470-01
$17,449
TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION [199466]
Gross
$26,845
0003-3734-13
$16,869
NIVOLUMAB 100 MG/10 ML INTRAVENOUS SOLUTION [169181]
Gross
$25,952
57894-503-01
$16,842
DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN [188662]
Gross
$25,911
73475-3041-5
$16,715
EFGARTIGIMOD ALFA-FCAB (VYVGART) INFUSION [4083352]
Gross
$25,715
0074-5015-01
$16,706
RISANKIZUMAB (SKYRIZI) INFUSION [4083277]
Gross
$25,702
0003-2327-11
$16,633
IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION [150563]
Gross
$25,589
50242-061-01
$15,540
BEVACIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [38022]
Gross
$23,908
15054-1120-4
$15,538
LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE [87861]
Gross
$23,905
0173-0892-42
$15,206
MEPOLIZUMAB 100 MG/ML SUBCUTANEOUS SYRINGE [185700]
Gross
$23,394
50242-260-01
$14,601
PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN [189241]
Gross
$22,463
51144-020-01
$13,514
ENFORTUMAB VEDOTIN-EJFV 20 MG INTRAVENOUS SOLUTION [187475]
Gross
$20,790
50242-053-06
$13,314
RITUXIMAB 10 MG/ML CONCENTRATE,INTRAVENOUS [22149]
Gross
$20,484
64406-008-01
$13,276
NATALIZUMAB (TYSABRI) INFUSION CPH [4083297]
Gross
$20,424
64764-300-20
$13,036
VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION [166819]
Gross
$20,055
68727-712-01
$12,652
LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION [189006]
Gross
$19,464
50242-176-01
$12,566
TENECTEPLASE 50 MG INTRAVENOUS SOLUTION [181909]
Gross
$19,333
36100063
$11,765
HC TRANSPERINEAL PLMT BIODEGRADABLE MATRL 1_MLT NJX
Gross
$18,100
57894-054-27
$11,489
USTEKINUMAB 130 MG/26 ML INTRAVENOUS SOLUTION [177086]
Gross
$17,675
51010333
$11,466
HC NASAL_SINUS NDSC DSTRJ RF ABLATION PST NSL NRV
Gross
$17,639
51010334
$11,466
HC NASAL_SINUS NDSC DSTRJ CRYOABLATION PST NSL NRV
Gross
$17,639
50242-145-01
$11,380
PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION [157879]
Gross
$17,508
66733-958-23
$11,323
CETUXIMAB 100 MG/50 ML INTRAVENOUS SOLUTION [37989]
Gross
$17,421
30000199
$10,994
HC EXOME SEQUNECE ANALYSIS
Gross
$16,914
65597-406-01
$10,909
FAM-TRASTUZUMAB DERUXTECAN-NXKI 100 MG INTRAVENOUS SOLUTION [187480]
Gross
$16,782
25682-025-01
$10,823
ULTOMIRIS 100 MG/ML INTRAVENOUS SOLUTION [190117]
Gross
$16,651
0078-0825-81
$10,776
OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE [170433]
Gross
$16,578
0310-3040-00
$10,725
ANIFROLUMAB-FNIA 300 MG/2 ML (150 MG/ML) INTRAVENOUS SOLUTION [192721]
Gross
$16,500
30000208
$10,235
HC UNLISTED MOLECULAR PATHOLOGY PROC_NEO COMP HEME CANCERS
Gross
$15,746
57894-350-01
$10,223
GOLIMUMAB 12.5 MG/ML INTRAVENOUS SOLUTION [163840]
Gross
$15,728
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 25682-028-01 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [190114] | $183,157 | $119,052 | — | — | 0 |
| 25682-025-0125682-028-01 | RAVULIZUMAB-CWVZ 100 MG/ML INTRAVENOUS SOLUTION [190114] | $154,296 | $100,292 | — | — | 0 |
| 50242-150-01 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION [178568] | $92,544 | $60,154 | — | — | 0 |
| 0003-7125-11 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION [194379] | $74,963 | $48,726 | — | — | 0 |
| 75987-080-10 | PEGLOTICASE 8 MG/ML INTRAVENOUS SOLUTION [148751] | $67,705 | $44,008 | — | — | 0 |
| 0469-4425-30 | ZOLBETUXIMAB-CLZB 300 MG INTRAVENOUS SOLUTION [205659] | $60,000 | $39,000 | — | — | 0 |
| 0173-0898-03 | DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION [191781] | $58,710 | $38,162 | — | — | 0 |
| 0003-2328-22 | IPILIMUMAB 200 MG/40 ML (5 MG/ML) INTRAVENOUS SOLUTION [150564] | $50,093 | $32,560 | — | — | 0 |
| 51144-050-01 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION [153019] | $44,692 | $29,050 | — | — | 0 |
| 72493-103-03 | MITOMYCIN 40 MG X 2 INTRA-PYELOCALYCEAL KIT [188495] | $41,911 | $27,242 | — | — | 0 |
| 72903-853-01 | MIRVETUXIMAB SORAVTANSINE-GYNX 5 MG/ML INTRAVENOUS SOLUTION [195098] | $41,092 | $26,710 | — | — | 0 |
| 47335-177-95 | TILDRAKIZUMAB-ASMN 100 MG/ML SUBCUTANEOUS SYRINGE [182767] | $38,254 | $24,865 | — | — | 0 |
| 57894-505-20 | DARATUMUMAB 20 MG/ML INTRAVENOUS SOLUTION [173332] | $37,964 | $24,676 | — | — | 0 |
| 59572-775-01 | LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION [187194] | $37,435 | $24,333 | — | — | 0 |
| 50881-006-03 | RETIFANLIMAB-DLWR 500 MG/20 ML INTRAVENOUS SOLUTION [197773] | $36,858 | $23,957 | — | — | 0 |
| 57894-501-01 | AMIVANTAMAB-VMJW 50 MG/ML INTRAVENOUS SOLUTION [192080] | $36,463 | $23,701 | — | — | 0 |
| 0006-3026-04 | PEMBROLIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [169519] | $30,770 | $20,000 | — | — | 0 |
| 0310-4611-50 | DURVALUMAB 50 MG/ML INTRAVENOUS SOLUTION [179453] | $30,057 | $19,537 | — | — | 0 |
| 76100272 | HC BRONCHOSCOPY W_PLMT FIDUCIAL MARKERS SINGLE_MULT | $29,150 | $18,947 | — | — | 0 |
| 50242-917-01 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION [175551] | $28,546 | $18,555 | — | — | 0 |
| 61755-008-01 | CEMIPLIMAB-RWLC 50 MG/ML INTRAVENOUS SOLUTION [183555] | $27,265 | $17,722 | — | — | 0 |
| 57894-470-01 | TALQUETAMAB-TGVS 40 MG/ML SUBCUTANEOUS SOLUTION [199466] | $26,845 | $17,449 | — | — | 0 |
| 0003-3734-13 | NIVOLUMAB 100 MG/10 ML INTRAVENOUS SOLUTION [169181] | $25,952 | $16,869 | — | — | 0 |
| 57894-503-01 | DARATUMUMAB 1,800 MG-HYALURONIDASE-FIHJ 30,000 UNIT/15 ML SUBCUT SOLN [188662] | $25,911 | $16,842 | — | — | 0 |
| 73475-3041-5 | EFGARTIGIMOD ALFA-FCAB (VYVGART) INFUSION [4083352] | $25,715 | $16,715 | — | — | 0 |
| 0074-5015-01 | RISANKIZUMAB (SKYRIZI) INFUSION [4083277] | $25,702 | $16,706 | — | — | 0 |
| 0003-2327-11 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION [150563] | $25,589 | $16,633 | — | — | 0 |
| 50242-061-01 | BEVACIZUMAB 25 MG/ML INTRAVENOUS SOLUTION [38022] | $23,908 | $15,540 | — | — | 0 |
| 15054-1120-4 | LANREOTIDE 120 MG/0.5 ML SUBCUTANEOUS SYRINGE [87861] | $23,905 | $15,538 | — | — | 0 |
| 0173-0892-42 | MEPOLIZUMAB 100 MG/ML SUBCUTANEOUS SYRINGE [185700] | $23,394 | $15,206 | — | — | 0 |
| 50242-260-01 | PERTUZUMAB 600 MG-TRASTUZUMAB 600 MG-HYALURONID-ZZXF/10 ML SUBCUT SOLN [189241] | $22,463 | $14,601 | — | — | 0 |
| 51144-020-01 | ENFORTUMAB VEDOTIN-EJFV 20 MG INTRAVENOUS SOLUTION [187475] | $20,790 | $13,514 | — | — | 0 |
| 50242-053-06 | RITUXIMAB 10 MG/ML CONCENTRATE,INTRAVENOUS [22149] | $20,484 | $13,314 | — | — | 0 |
| 64406-008-01 | NATALIZUMAB (TYSABRI) INFUSION CPH [4083297] | $20,424 | $13,276 | — | — | 0 |
| 64764-300-20 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION [166819] | $20,055 | $13,036 | — | — | 0 |
| 68727-712-01 | LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION [189006] | $19,464 | $12,652 | — | — | 0 |
| 50242-176-01 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION [181909] | $19,333 | $12,566 | — | — | 0 |
| 36100063 | HC TRANSPERINEAL PLMT BIODEGRADABLE MATRL 1_MLT NJX | $18,100 | $11,765 | — | — | 0 |
| 57894-054-27 | USTEKINUMAB 130 MG/26 ML INTRAVENOUS SOLUTION [177086] | $17,675 | $11,489 | — | — | 0 |
| 51010333 | HC NASAL_SINUS NDSC DSTRJ RF ABLATION PST NSL NRV | $17,639 | $11,466 | — | — | 0 |
| 51010334 | HC NASAL_SINUS NDSC DSTRJ CRYOABLATION PST NSL NRV | $17,639 | $11,466 | — | — | 0 |
| 50242-145-01 | PERTUZUMAB 420 MG/14 ML (30 MG/ML) INTRAVENOUS SOLUTION [157879] | $17,508 | $11,380 | — | — | 0 |
| 66733-958-23 | CETUXIMAB 100 MG/50 ML INTRAVENOUS SOLUTION [37989] | $17,421 | $11,323 | — | — | 0 |
| 30000199 | HC EXOME SEQUNECE ANALYSIS | $16,914 | $10,994 | — | — | 0 |
| 65597-406-01 | FAM-TRASTUZUMAB DERUXTECAN-NXKI 100 MG INTRAVENOUS SOLUTION [187480] | $16,782 | $10,909 | — | — | 0 |
| 25682-025-01 | ULTOMIRIS 100 MG/ML INTRAVENOUS SOLUTION [190117] | $16,651 | $10,823 | — | — | 0 |
| 0078-0825-81 | OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE [170433] | $16,578 | $10,776 | — | — | 0 |
| 0310-3040-00 | ANIFROLUMAB-FNIA 300 MG/2 ML (150 MG/ML) INTRAVENOUS SOLUTION [192721] | $16,500 | $10,725 | — | — | 0 |
| 30000208 | HC UNLISTED MOLECULAR PATHOLOGY PROC_NEO COMP HEME CANCERS | $15,746 | $10,235 | — | — | 0 |
| 57894-350-01 | GOLIMUMAB 12.5 MG/ML INTRAVENOUS SOLUTION [163840] | $15,728 | $10,223 | — | — | 0 |
Showing top 50 of 20,889 priced procedures, sorted by gross charge.
Data straight from this hospital's own published price file (45 CFR § 180). The grade scores how completely the file contains the six required data elements. It is a check of the file — not a CMS compliance ruling, and not a measure of quality of care.